IMAGE (IMAGE)
Caption
The new compound EnPGC-1, which activates the mitochondria of mouse T cells, can make cancer immunotherapy more efficient.
Credit
Mindy Takamiya/Kyoto University iCeMS
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted. Adaptations must be shared under the same terms.
License
CC BY-NC-SA